While the FDA may consider an emergency use authorization, a coronavirus vaccine likely won’t be accessible to the general public until next year, says Healthcare Policy Analyst Chris Meekins.
Recorded June 24, 2020.
Markets & Investing July 01, 2022 Where can investors turn when the markets are a riddle? Raymond James...
Markets & Investing July 01, 2022 Review the latest portfolio strategy commentary from Mike Gibbs,...
Economy & Policy July 01, 2022 Chief Economist Eugenio J. Alemán discusses current economic...